Reviewing BZAM (OTCMKTS:BZAMF) and Prestige Consumer Healthcare (NYSE:PBH)

Prestige Consumer Healthcare (NYSE:PBH – Get Free Report) and BZAM (OTCMKTS:BZAMF – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability. Earnings and Valuation This table compares Prestige Consumer Healthcare and BZAM”s revenue, earnings per share and valuation. | Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | | | Prestige Consumer Healthcare | $1.09 billion | 2.16 | $190.30 million | $3.91 | 12.70 | | BZAM | N/A | N/A | N/A | ($0.27) | N/A | Profitability This table compares Prestige Consumer Healthcare and BZAM’s net margins, return on equity and return on assets. | Net Margins | Return on Equity | Return on Assets | | | Prestige Consumer Healthcare | 17.48% | 11.54% | 6.16% | | BZAM | N/A | N/A | N/A | Analyst Recommendations This is a breakdown of current recommendations and price targets for Prestige Consumer Healthcare and BZAM, as reported by MarketBeat. | Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | | | Prestige Consumer Healthcare | 2 | 2 | 2 | 0 | 2.00 | | BZAM | 0 | 0 | 0 | 0 | 0.00 | Prestige Consumer Healthcare presently has a consensus target price of $70.75, indicating a potential upside of 42.43%. Given Prestige Consumer Healthcare’s stronger consensus rating and higher probable upside, analysts plainly believe Prestige Consumer Healthcare is more favorable than BZAM. Insider and Institutional Ownership 100.0% of Prestige Consumer Healthcare shares are owned by institutional investors. Comparatively, 0.0% of BZAM shares are owned by institutional investors. 1.5% of Prestige Consumer Healthcare shares are owned by insiders. Comparatively, 8.7% of BZAM shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Summary Prestige Consumer Healthcare beats BZAM on 9 of the 10 factors compared between the two stocks. About Prestige Consumer Healthcare Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York. About BZAM BZAM Ltd. operates as a cannabis producer with a focus on branded consumer goods. Its brands include the BZAM, TGOD, ness, Highly Dutch Organic, and TABLE TOP, as well as Dunn Cannabis, FRESH, and Wyld partner brands. The company operate facilities in British Columbia, Alberta, Ontario, and Quebec, as well as retail stores in Winnipeg, Manitoba and Regina, Saskatchewan. The company was formerly known as The Green Organic Dutchman Holdings Ltd. and changed its name to BZAM Ltd. in February 2023. The company was incorporated in 2016 and is headquartered in Vancouver, Canada. Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.